Durée : 13 hours
Dates : Du 11 au 12 juin 2026
Lieu : Villejuif
Frais d'inscription : Free of charge for students (Master’s students, PhD candidates, and Postdoctoral fellows)/ Please select the reduced rate and upload supporting documentation. Your registration will be approved after verification by the teaching assistant ; €250 for practicing physicians, residents (CCA), scientists, and other academic staff (nurses, radiologic technologists, etc.), eligible for funding through professional or HR accounts, as well as for private-practice nurses and private-practice physicians (by selecting the “reduced rate” option) ; €750 for employees of the pharmaceutical and biotechnology industries
Nombre maximal de participants : 130 seats available
Contact et inscription :
Description
The Intratumoral Immunotherapy Symposium 2026 is an intensive two-day training program, jointly organized by Gustave Roussy, dedicated to intratumoral immunotherapy—an innovative therapeutic approach aimed at stimulating the immune response directly within tumors.
Participants will gain a comprehensive understanding of the fundamental principles, historical evolution, and most recent clinical developments in this rapidly advancing field. The program combines scientific lectures, clinical case studies, innovative drug delivery technologies, and discussions on regulatory and operational aspects. Sessions will also include interactive panel discussions, fostering exchanges on current challenges and future perspectives in intratumoral immunotherap
Subscription to The Intratumoral Immunotherapy Symposium
Subscription on Gustave Roussy Education website : Click here
Objectifs pédagogiques
By the end of this training, participants will be able to:
- Understand the principles and historical development of intratumoral immunotherapy, from Coley’s toxins to the most recent clinical approvals.
- Identify intratumoral agents currently in clinical development, their promising results, and local therapeutic approaches beyond immunotherapy.
- Explore innovative delivery technologies, including image-guided, bronchoscopic, and intracranial administration.
- Apply lesion selection strategies for injection based on tumor biology, imaging, and ImmunoPET.
- Monitor and analyze therapeutic responses using RECIST, IT RECIST, radiomics, and biomarkers.
- Draw lessons from phase III intratumoral clinical trials and understand clinical, operational, and regulatory challenges.
- Design and plan intratumoral clinical trials in accordance with SITC recommendations and integrate local therapies into the patient care pathway, from neoadjuvant settings to metastatic disease.
- Promote cross-sector collaboration and strategic discussion to accelerate the development of new intratumoral therapies.
Détails du programme
Download the program here
Public concerné
Physicians, researchers, pharmacists, and scientists involved in immunotherapy research and development, offering a balanced perspective across fundamental science, clinical practice, and technological innovation.
Conditions préalables
- Belonging to the target audience.
- Completion of the “Getting to Know You” form, which will be available in your personal space once your registration has been validated by the training assistant.
Méthodes et moyens pédagogiques
Access Modalities
- On-site training: 2 days in person
- (Please note that a change of modality at the last minute will not be possible for catering reasons.)
- Online training: 2 days fully virtual
Oral Sessions
- Conducted in English
Educational Tools
- Practical scenarios and case-based learning
- Interactive Q&A sessions between participants and faculty
- Training materials available shortly after the symposium
- (replay videos and PDF presentations)
Méthodes d'évaluation
- Knowledge assessment: a final test to be completed at the end of the training.
- Satisfaction assessment: a satisfaction questionnaire to be completed by each participant.
- Certificate of attendance: upon completion of the final test and receipt of signed attendance sheets, a certificate of completion will be made available in your personal space on the platform.
Coordination
Scientific Committee
- Prof. Benjamin Besse
- Dr. Roberto Casal
- Prof. Éric Deutsch
- Dr. Frederick Lang
- Dr. Sarina Piha-Paul
- Prof. Caroline Robert
Organizing Committee
- Dr. Stéphane Champiat
- Prof. Aurélien Marabelle
- Prof. Lambros Tselikas
- Dr. Rahul Sheth
Clôture des inscriptions
05/06/2026
